Image X Institute, Sydney School of Health Sciences, The University of Sydney & Ingham Institute for Applied Medical Research, Sydney, Australia
Sydney, Australia
Dr Caterina Brighi (PhD, MRes, MSci) is a Postdoctoral Research Associate at the Image X Institute, University of Sydney leading interdisciplinary clinical trials to improve brain cancer imaging. Her background is in brain cancer MRI/PET imaging and nanomedicine. Dr Brighi graduated with a MSci (Hons) degree in Chemistry with Molecular Physics (2015) and a MRes degree in Bioimaging Sciences (2016) from Imperial College London. In 2020 she completed her PhD in Bioengineering and Nanotechnology from the University of Queensland. As an early career researcher Dr Brighi works within the NHMRC funded Australian MRI-Linac Program, leading collaborations with major Australian and international cancer research centres and industry partners to develop novel MRI-based approaches that will improve radiotherapy for brain cancer patients. Dr Brighi research interest focusses on using quantitative MRI and PET imaging techniques to characterise different aspects of the tumour biology (such as cellularity, vascularisation, hypoxia and metabolism) and building workflows that will allow clinicians to integrate this information in the development of more efficient, personalised radiotherapy treatment plans for patients with brain cancer. She is an active member of the International Society for Magnetic Resonance in Medicine and of the Cooperative Trials Group for Neuro-Oncology (COGNO). In 2019 she was awarded the Young Investigator Award at the COGNO Annual Scientific Meeting and in 2021 she was awarded the Best Early and Mid Career Researcher Oral Presentation Award at the Sydney Cancer Conference.